Red blood cell transfusion: a clinical practice guideline from the AABB*
- PMID: 22751760
- DOI: 10.7326/0003-4819-157-1-201206190-00429
Red blood cell transfusion: a clinical practice guideline from the AABB*
Abstract
Description: Although approximately 85 million units of red blood cells (RBCs) are transfused annually worldwide, transfusion practices vary widely. The AABB (formerly, the American Association of Blood Banks) developed this guideline to provide clinical recommendations about hemoglobin concentration thresholds and other clinical variables that trigger RBC transfusions in hemodynamically stable adults and children.
Methods: These guidelines are based on a systematic review of randomized clinical trials evaluating transfusion thresholds. We performed a literature search from 1950 to February 2011 with no language restrictions. We examined the proportion of patients who received any RBC transfusion and the number of RBC units transfused to describe the effect of restrictive transfusion strategies on RBC use. To determine the clinical consequences of restrictive transfusion strategies, we examined overall mortality, nonfatal myocardial infarction, cardiac events, pulmonary edema, stroke, thromboembolism, renal failure, infection, hemorrhage, mental confusion, functional recovery, and length of hospital stay. RECOMMENDATION 1: The AABB recommends adhering to a restrictive transfusion strategy (7 to 8 g/dL) in hospitalized, stable patients (Grade: strong recommendation; high-quality evidence). RECOMMENDATION 2: The AABB suggests adhering to a restrictive strategy in hospitalized patients with preexisting cardiovascular disease and considering transfusion for patients with symptoms or a hemoglobin level of 8 g/dL or less (Grade: weak recommendation; moderate-quality evidence). RECOMMENDATION 3: The AABB cannot recommend for or against a liberal or restrictive transfusion threshold for hospitalized, hemodynamically stable patients with the acute coronary syndrome (Grade: uncertain recommendation; very low-quality evidence). RECOMMENDATION 4: The AABB suggests that transfusion decisions be influenced by symptoms as well as hemoglobin concentration (Grade: weak recommendation; low-quality evidence).
Comment in
-
Indications for blood transfusions: too complex to base on a single number?Ann Intern Med. 2012 Jul 3;157(1):71-2. doi: 10.7326/0003-4819-157-1-201206190-00431. Ann Intern Med. 2012. PMID: 22751765 No abstract available.
-
Red blood cell transfusion.Ann Intern Med. 2012 Nov 20;157(10):753-4; author reply 754-5. doi: 10.7326/0003-4819-157-10-201211200-00019. Ann Intern Med. 2012. PMID: 23165669 No abstract available.
Similar articles
-
Restrictive versus liberal red blood cell transfusion strategies for people with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem cell support.Cochrane Database Syst Rev. 2017 Jan 27;1(1):CD011305. doi: 10.1002/14651858.CD011305.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2024 May 23;5:CD011305. doi: 10.1002/14651858.CD011305.pub3. PMID: 28128441 Free PMC article. Updated.
-
Transfusion thresholds for guiding red blood cell transfusion.Cochrane Database Syst Rev. 2021 Dec 21;12(12):CD002042. doi: 10.1002/14651858.CD002042.pub5. Cochrane Database Syst Rev. 2021. PMID: 34932836 Free PMC article.
-
Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion.Cochrane Database Syst Rev. 2016 Oct 12;10(10):CD002042. doi: 10.1002/14651858.CD002042.pub4. Cochrane Database Syst Rev. 2016. Update in: Cochrane Database Syst Rev. 2021 Dec 21;12:CD002042. doi: 10.1002/14651858.CD002042.pub5. PMID: 27731885 Free PMC article. Updated.
-
Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion.Cochrane Database Syst Rev. 2012 Apr 18;4(4):CD002042. doi: 10.1002/14651858.CD002042.pub3. Cochrane Database Syst Rev. 2012. Update in: Cochrane Database Syst Rev. 2016 Oct 12;10:CD002042. doi: 10.1002/14651858.CD002042.pub4. PMID: 22513904 Free PMC article. Updated.
-
Benefits and harms of red blood cell transfusions in patients with septic shock in the intensive care unit.Dan Med J. 2016 Feb;63(2):B5209. Dan Med J. 2016. PMID: 26836806 Clinical Trial.
Cited by
-
Red blood cell transfusion strategies and Maximum surgical blood ordering schedule.Indian J Anaesth. 2014 Sep;58(5):581-9. doi: 10.4103/0019-5049.144660. Indian J Anaesth. 2014. PMID: 25535420 Free PMC article. Review.
-
Life-Threatening Transfusion Reaction in Postoperative Total Knee Arthroplasty: A Unique Case and Comprehensive Insights.J Orthop Case Rep. 2024 Sep;14(9):173-177. doi: 10.13107/jocr.2024.v14.i09.4770. J Orthop Case Rep. 2024. PMID: 39253651 Free PMC article.
-
The Influence of Clinical and Biological Factors on Transfusion-Associated Non-ABO Antigen Alloimmunization: Responders, Hyper-Responders, and Non-Responders.Transfus Med Hemother. 2014 Nov;41(6):420-9. doi: 10.1159/000369109. Epub 2014 Nov 17. Transfus Med Hemother. 2014. PMID: 25670929 Free PMC article. Review.
-
Potential cost saving of Epoetin alfa in elective hip or knee surgery due to reduction in blood transfusions and their side effects: a discrete-event simulation model.PLoS One. 2013 Sep 9;8(9):e72949. doi: 10.1371/journal.pone.0072949. eCollection 2013. PLoS One. 2013. PMID: 24039829 Free PMC article.
-
Cost of post-operative intravenous iron therapy in total lower limb arthroplasty: a retrospective, matched cohort study.Blood Transfus. 2014 Jan;12(1):40-9. doi: 10.2450/2013.0088-13. Epub 2013 Oct 3. Blood Transfus. 2014. PMID: 24120595 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical